ZANTAC IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Zantac In Plastic Container patents expire, and what generic alternatives are available?
Zantac In Plastic Container is a drug marketed by Pai Holdings Pharm and is included in one NDA.
The generic ingredient in ZANTAC IN PLASTIC CONTAINER is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zantac In Plastic Container
A generic version of ZANTAC IN PLASTIC CONTAINER was approved as ranitidine hydrochloride by SANDOZ on August 29th, 1997.
Summary for ZANTAC IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 22 |
Patent Applications: | 2,243 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZANTAC IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ZANTAC IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Spaulding Clinical Research LLC | Phase 1 |
Food and Drug Administration (FDA) | Phase 1 |
Dalhousie University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ZANTAC IN PLASTIC CONTAINER
US Patents and Regulatory Information for ZANTAC IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZANTAC IN PLASTIC CONTAINER
International Patents for ZANTAC IN PLASTIC CONTAINER
See the table below for patents covering ZANTAC IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 2384765 | DERIVES AMINO-SUBSTITUES DU FURANNE ET PROCEDE POUR LEUR PREPARATION | ⤷ Try a Trial |
Sweden | 453500 | RANITIDIN-HYDROKLORID FORM 2, FORFARANDE FOR FRAMSTELLNING DERAV SAMT FARMACEUTISK KOMPOSITION INNEHALLANDE NEMNDA FORENING MED HISTAMIN-H?712-BLOCKERANDE VERKAN | ⤷ Try a Trial |
United Kingdom | 8313217 | ⤷ Try a Trial | |
Japan | S55153779 | NOVEL AMINES | ⤷ Try a Trial |
Switzerland | 647517 | Amine compounds | ⤷ Try a Trial |
Ireland | 57397 | PHARMACEUTICAL COMPOSITIONS | ⤷ Try a Trial |
Yugoslavia | 40006 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |